Roflumilast enhances cisplatin‐sensitivity and reverses cisplatin‐resistance of ovarian cancer cells via cAMP/PKA/CREB‐FtMt signalling axis

по Gong, Shipeng, Chen, Yongning, Meng, Fanliang, Zhang, Yadi, Li, Chanyuan, Zhang, Guangping, Huan, Wu, Wu, Fei
Опубликовано в: Cell Prolif (2018)